Streetbeat News

Price Targets

CALX

Rosenblatt analyst Mike Genovese has reiterated a 'Buy' rating on Calix (NYSE:CALX) and maintained a price target of $70.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 11:00 am

FHN

Baird analyst David George has initiated coverage on First Horizon (NYSE:FHN) with a Neutral rating and a price target of $14.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 10:57 am

INTS

Benchmark analyst Robert Wasserman has initiated coverage on Intensity Therapeutics (NASDAQ:INTS) with a Speculative Buy rating and a price target of $12.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 10:56 am

LPX

TD Securities has downgraded Louisiana-Pacific (NYSE:LPX) from Buy to Hold and set a price target of $86.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 10:55 am

LITE

B of A Securities analyst Vivek Arya has downgraded Lumentum Holdings (NASDAQ:LITE) from Neutral to Underperform and set a price target of $50.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 10:54 am

MTSI

B of A Securities analyst Vivek Arya has downgraded MACOM Technology Solns (NASDAQ:MTSI) from Buy to Neutral and set a price target of $72.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 10:54 am

COHR

B of A Securities analyst Vivek Arya has downgraded Coherent (NYSE:COHR) from Buy to Neutral and announced a $55 price target.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 10:53 am

CAMT

B of A Securities analyst Vivek Arya has upgraded Camtek (NASDAQ:CAMT) from Neutral to Buy and raised the price target from $30 to $50.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 10:52 am

CPT

BMO Capital analyst John Kim has upgraded Camden Prop Trust (NYSE:CPT) from Market Perform to Outperform and raised the price target from $125 to $126.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 10:51 am

CABA

Guggenheim analyst Yatin Suneja has initiated coverage on Cabaletta Bio (NASDAQ:CABA) with a Buy rating and a price target of $34.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 10:38 am